TP010/#242 AFT-50 EndoMAP: a phase IB/II multicohort study of targeted agents with atezolizumab (ATEZO) for patients (PTS) with recurrent or persistent endometrial cancer (EC)
E-Posters (Trials In Progress)(2022)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined